Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Sunitinib × 1 year × Clear all

Phase

Phase 2 21 Phase 3 18 Phase 1 5 Phase 1/2 3 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Dexamethasone 14 Fluorouracil 9 Saline Solution 8 Carboplatin 8 Bupivacaine 8 Bevacizumab 8 Tobacco Use Cessation Devices 7 Nivolumab 7 Lenalidomide 7 pembrolizumab 6 anlotinib 6 Specimen Handling 6 Rituximab 6 Prednisone 6 Magnetic Resonance Spectroscopy 6 Letrozole 6 Human Papillomavirus Recombinant Vaccine nonavalent 6 Cisplatin 6 Standard of Care 5 Propofol 5 trametinib 4 lenvatinib 4 ibrutinib 4 dabrafenib 4 cabozantinib 4 Trastuzumab 4 Tamoxifen 4 Surveys and Questionnaires 4 Sodium Chloride 4 Ropivacaine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02555748 2026-03-31

SUP-R

Institut Claudius Regaud

Phase 4 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡